Hetaryl-[1,8]naphthyridine derivatives

US8912216B2 · kind B2 · utility

Assignee

• Merck Patent GmbH · DE

Inventors

• Alfred Jonczyk · Darmstadt, DE
• Dieter Dorsch · Ober-Ramstadt, DE
• Guenter Hoelzemann · Seeheim-Jugenheim, DE
• Christiane Amendt · Mühltal, DE
• Frank Zenke · Darmstadt, DE

Key dates

• Filing date: Oct 4, 2013
• Grant date: Dec 16, 2014
• Expiry date: Oct 4, 2033

Classification

• Technology area (CPC C): Chemistry; Metallurgy
• CPC primary: C07D519/00
• WIPO field: Pharmaceuticals
• WIPO sector: Chemistry

Abstract

Novel hetaryl-[1,8]naphthyridine derivatives of formula (I)wherein R1, R2, W1, W3, W5 and W6 have the meaning according to claim 1, are inhibitors of ATP consuming proteins, and can be employed, inter alia, for the treatment of tumors.